Growth Metrics

Angiodynamics (ANGO) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to $72.0 million.

  • Angiodynamics' Total Current Liabilities fell 1877.31% to $72.0 million in Q4 2025 from the same period last year, while for Nov 2025 it was $72.0 million, marking a year-over-year decrease of 1877.31%. This contributed to the annual value of $76.2 million for FY2025, which is 1640.94% down from last year.
  • As of Q4 2025, Angiodynamics' Total Current Liabilities stood at $72.0 million, which was down 1877.31% from $68.3 million recorded in Q3 2025.
  • In the past 5 years, Angiodynamics' Total Current Liabilities ranged from a high of $91.2 million in Q2 2024 and a low of $49.4 million during Q1 2022
  • Over the past 5 years, Angiodynamics' median Total Current Liabilities value was $72.8 million (recorded in 2022), while the average stood at $70.2 million.
  • In the last 5 years, Angiodynamics' Total Current Liabilities surged by 4104.68% in 2023 and then crashed by 1877.31% in 2025.
  • Over the past 5 years, Angiodynamics' Total Current Liabilities (Quarter) stood at $54.5 million in 2021, then skyrocketed by 35.05% to $73.6 million in 2022, then increased by 6.08% to $78.0 million in 2023, then rose by 13.53% to $88.6 million in 2024, then fell by 18.77% to $72.0 million in 2025.
  • Its Total Current Liabilities stands at $72.0 million for Q4 2025, versus $68.3 million for Q3 2025 and $76.2 million for Q2 2025.